Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The ATP-sensitive potassium channel (KATP channel) in pancreatic beta cells is a crucial molecular sensor that links cellular metabolism to electrical activity, thereby regulating insulin secretion. It plays a central role in glucose homeostasis by coupling changes in intracellular ATP/ADP ratios—reflecting metabolic status—to the membrane potential and subsequent insulin release. The KATP channel is a hetero-octameric complex composed of four pore-forming Kir6.2 subunits and four regulatory sulfonylurea receptor 1 (SUR1) subunits. At low glucose concentrations, KATP channels remain open, keeping the beta cell membrane hyperpolarized and suppressing insulin secretion. When blood glucose rises, increased metabolism elevates intracellular ATP levels. ATP binds to and inhibits KATP channels, causing them to close, leading to membrane depolarization, opening voltage-dependent calcium channels, and triggering exocytosis of insulin-containing granules. Sulfonylurea drugs bind SUR1 subunits and close the channel independently of ATP levels, stimulating insulin release. Mutations can cause neonatal diabetes (gain-of-function) or congenital hyperinsulinism (loss-of-function). Polymorphisms such as E23K in Kir6.2 are associated with an increased risk for late-onset type 2 diabetes.
Sulfonylureas bind to SUR1 subunits and close the channel independently of ATP levels, stimulating insulin release.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on ATP-Sensitive Potassium Channel on Pancreatic Beta Cell (KATP channel).